Copyright
©The Author(s) 2022.
World J Clin Cases. Jul 26, 2022; 10(21): 7483-7494
Published online Jul 26, 2022. doi: 10.12998/wjcc.v10.i21.7483
Published online Jul 26, 2022. doi: 10.12998/wjcc.v10.i21.7483
Figure 2 Sanger sequencing images of pedigree mutation type in SLC12A3.
The sequence diagram from the first to the fourth row represents the mother, father, proband, and son or daughter, respectively. A: The NM_000339.2:c.488C>T(p.Thr163Met) (indicated by the red arrow) is a heterozygous missense mutation in exon 3; B: The NM_000339.2:c.1171_1178dupGCCACCAT(p.Ile393fs) (indicated by the red arrow) is a heterozygous frameshift mutation in exon 9; C: The NM_000339.2:c.2612G>A(p.Arg871His) (indicated by the red arrow) is a heterozygous missense mutation in exon 22.
- Citation: Qin YZ, Liu YM, Wang Y, You C, Li LN, Zhou XY, Lv WM, Hong SH, Xiao LX. Novel compound heterozygous mutation of SLC12A3 in Gitelman syndrome co-existent with hyperthyroidism: A case report and literature review. World J Clin Cases 2022; 10(21): 7483-7494
- URL: https://www.wjgnet.com/2307-8960/full/v10/i21/7483.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i21.7483